Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Recurrent Large Cell Lung Carcinoma,Recurrent Lung Adenocarcinoma,Recurrent Squamous Cell Lung Carcinoma,Stage IV Large Cell Lung Carcinoma,Stage IV Lung Adenocarcinoma,Stage IV Squamous Cell Lung Carcinoma
Study Phase
Phase 3
Study Completion Date
August 2017
NCT00946712Uploaded 06-05-2021
Access via NCI by Request
PDS UID: nci-data-470
A Randomized, Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab With or Without Concurrent Cetuximab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
Files: NCT00946712-D1
Data DictionaryNCT00946712-D1-Data-Dictionary_5.pdf
DATANCT00946712-D1-Dataset_5.csv
OTHERREADME.pdf
Files: NCT00946712-D2
Data DictionaryNCT00946712-D2-Data-Dictionary_4.pdf
DATANCT00946712-D2-Dataset_5.csv
OTHERREADME.pdf
Files: NCT00946712-D3
Data DictionaryNCT00946712-D3-Data-Dictionary_2.pdf
DATANCT00946712-D3-Dataset_3.csv
OTHERREADME.pdf